Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus plus tacrolimus vs tacrolimus alone in de novo liver transplant recipients
2011-003118-17Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of everolimus in immunocompromise (2 arms), sponsored by Novartis. Started Jan 2012; status: completed.
02
Drugs
everolimus
03
Conditions
immunocompromise
Beyond the preview
Go deeper on 2011-003118-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003118-17.